How many institutions held BLTE - BELITE BIO, INC - Ordinary shares, par value US$0.0001 per share in Q1 2025?

18 institutional investors reported BLTE - BELITE BIO, INC - Ordinary shares, par value US$0.0001 per share for Q1 2025. Use the holders table for investor-level position and value details.

BELITE BIO, INC - Ordinary shares, par value US$0.0001 per share (BLTE)

Q: What does CUSIP 07782B104 represent in this 13F holders report?

CUSIP 07782B104 is the security identifier for BLTE - BELITE BIO, INC - Ordinary shares, par value US$0.0001 per share used to aggregate holder disclosures.

CUSIP: 07782B104

Q1 2025 13F Holders as of 31 Mar 2025

Security type / class: Equity / Ordinary shares, par value US$0.0001 per share
Shares outstanding: 40,449,516
Total 13F shares: 149,657
Share change: -130,299
Total reported value: $9,909,658
Reported price per share: $66.22
Number of holders: 18
Value change: -$8,038,751
Number of buys: 12
Number of sells: 14

Security key

07782B104

Report period

Q1 2025

Institutions

Top holders

BLTE full security history Ownership snapshot Full 13F holder table Newer quarter: Q2 2025 Previous quarter: Q4 2024 BELITE BIO, INC SEC filings BELITE BIO, INC company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 07782B104

Newer quarter: Q2 2025 Previous quarter: Q4 2024

Recent filing periods:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Ownership snapshot

Top reported holders of BLTE - BELITE BIO, INC - Ordinary shares, par value US$0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder

Lin Bioscience Internatio...

13D/G signal

Lin Bioscience Internatio...

Evidence rows

Latest as of

31 Dec 2024

13D/G 13F Lead comparable stake: 54% 13D/G row: Lin Bioscience International Ltd. Showing 1-6 of 15 holder rows.

Rank 1 holder

Lin Bioscience International Ltd.

13D/G

Ownership: 54%
Position: $1.07B

13D/G

Rank 2 holder

ARMISTICE CAPITAL, LLC

13F

Ownership: 0.42%
Position: $10.6M

13F

Rank 3 holder

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Lin Bioscience International Ltd.	13D/G 13D/G	54%	$1,065,034,885 17,095,263 shares	$0	31 Dec 2024
ARMISTICE CAPITAL, LLC	13F Company 13F	0.42%	$10,596,383 167,930 shares	—	31 Dec 2024
STATE STREET CORP	13F Company 13F	0.05%	$1,263,073 20,017 shares	—	31 Dec 2024
BANK OF AMERICA CORP /DE/	13F Company 13F	0.05%	$1,157,381 18,342 shares	—	31 Dec 2024
JPMORGAN CHASE & CO	13F Company 13F	0.04%	$923,532 14,636 shares	—	31 Dec 2024
UBS Group AG	13F Company 13F	0.03%	$770,262 12,207 shares	—	31 Dec 2024

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

149,657

Rows available

Investor	Option	Weight %	Change %	Reported value	* Price	Shares	Share Change	Activity	Report Period

^* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q1 2025 vs Q4 2024 Across Filers

Q4 2024 holders

Q1 2025 holders

Holder diff

-3

Investor	Q4 2024 Shares	Q1 2025 Shares	Share Diff	Share Chg %	Q4 2024 value	Q1 2025 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend